JP2025163025A5 - - Google Patents
Info
- Publication number
- JP2025163025A5 JP2025163025A5 JP2025113059A JP2025113059A JP2025163025A5 JP 2025163025 A5 JP2025163025 A5 JP 2025163025A5 JP 2025113059 A JP2025113059 A JP 2025113059A JP 2025113059 A JP2025113059 A JP 2025113059A JP 2025163025 A5 JP2025163025 A5 JP 2025163025A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- amino acid
- acid sequence
- polypeptide
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662421332P | 2016-11-13 | 2016-11-13 | |
| US62/421,332 | 2016-11-13 | ||
| JP2019524445A JP2020502056A (ja) | 2016-11-13 | 2017-11-13 | 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法 |
| PCT/US2017/061343 WO2018089909A1 (en) | 2016-11-13 | 2017-11-13 | Compositions and methods for treating diabetes, hypertension and hypercholesterolemia |
| JP2023016485A JP7711967B2 (ja) | 2016-11-13 | 2023-02-07 | 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023016485A Division JP7711967B2 (ja) | 2016-11-13 | 2023-02-07 | 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025163025A JP2025163025A (ja) | 2025-10-28 |
| JP2025163025A5 true JP2025163025A5 (enExample) | 2026-02-06 |
Family
ID=62107069
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019524445A Pending JP2020502056A (ja) | 2016-11-13 | 2017-11-13 | 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法 |
| JP2023016485A Active JP7711967B2 (ja) | 2016-11-13 | 2023-02-07 | 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法 |
| JP2025113059A Pending JP2025163025A (ja) | 2016-11-13 | 2025-07-03 | 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019524445A Pending JP2020502056A (ja) | 2016-11-13 | 2017-11-13 | 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法 |
| JP2023016485A Active JP7711967B2 (ja) | 2016-11-13 | 2023-02-07 | 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10548941B2 (enExample) |
| EP (1) | EP3538124A4 (enExample) |
| JP (3) | JP2020502056A (enExample) |
| KR (1) | KR102497242B1 (enExample) |
| CN (1) | CN110087666B (enExample) |
| AU (2) | AU2017357052B2 (enExample) |
| BR (1) | BR112019009511A2 (enExample) |
| MX (1) | MX2019005466A (enExample) |
| WO (1) | WO2018089909A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110087666B (zh) * | 2016-11-13 | 2024-04-30 | 想象制药公司 | 用于治疗糖尿病、高血压和高胆固醇血症的组合物和方法 |
| JP2021510157A (ja) * | 2018-01-09 | 2021-04-15 | イマジン ファーマ、エルエルシー | 内皮細胞機能障害を調節するためのｒｐｓ２ペプチドの使用 |
| WO2020005721A1 (en) * | 2018-06-25 | 2020-01-02 | Imagine Pharma, Llc | Compositions and methods for propagating insulin-producing islet cells and therapeutic uses thereof |
| CN110974943A (zh) * | 2019-12-09 | 2020-04-10 | 广东药科大学 | 一种口服胰岛素药物制剂及其制备方法 |
| JP2023552515A (ja) * | 2020-12-08 | 2023-12-18 | イマジン ファーマ、エルエルシー | 創傷を治療するための組成物および方法 |
| WO2023049079A2 (en) * | 2021-09-22 | 2023-03-30 | Imagine Pharma Llc | Compositions and methods for propogating insulin and glucagon secreting cells from type 1 diabetic pancreatic tissue and therapeutic uses thereof |
| CA3235948A1 (en) * | 2021-12-11 | 2023-06-15 | Ngoc THAI | Compositions and methods for oral administration |
| WO2025207834A1 (en) * | 2024-03-28 | 2025-10-02 | Imagine Pharma Llc | Dietary supplements, compositions, and uses thereof for increasing telomerase activity and extending telomere length |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4025395B2 (ja) * | 1997-04-09 | 2007-12-19 | 花王株式会社 | 新規ペクチン酸リアーゼ |
| US20020042062A1 (en) * | 1999-09-24 | 2002-04-11 | Mark Stearns | Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms |
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| AUPR311601A0 (en) * | 2001-02-15 | 2001-03-08 | Adp Pharmaceutical Pty Limited | Matrix gene expression in chondrogenesis |
| US20050118151A1 (en) * | 2001-05-29 | 2005-06-02 | Syddansk Universitet | Proteins in diabetes proteome anlysis |
| US20040014040A1 (en) * | 2001-07-10 | 2004-01-22 | Donna Mendrick | Cardiotoxin molecular toxicology modeling |
| EP2275120A3 (en) * | 2002-04-02 | 2011-06-08 | Ben-Gurion University Of The Negev Research And Development Authority | Protein-based streptococcus pneumoniae vaccines |
| AU2004251654A1 (en) * | 2003-06-02 | 2005-01-06 | Icoria, Inc. | Use of genes differentially expressed during aging of liver for treatment and diagnosis |
| JP2005245202A (ja) * | 2004-03-01 | 2005-09-15 | Japan Science & Technology Agency | ヒトＴＦＩＩＥαの新規な亜鉛結合ドメインの構造的特徴および機能 |
| US20090048199A1 (en) * | 2007-03-09 | 2009-02-19 | Hiberna Corporation | Hibernation-Related Genes and Proteins, Activators and Inhibitors Thereof and Methods of Use |
| US9221886B2 (en) * | 2009-04-28 | 2015-12-29 | President And Fellows Of Harvard College | Supercharged proteins for cell penetration |
| WO2012054739A2 (en) * | 2010-10-21 | 2012-04-26 | New York University | Structure-guided identification of binding interactions of human laminin receptor precursor with laminin and identification of compounds that affect binding |
| CA2817851A1 (en) * | 2010-11-12 | 2012-05-18 | The Johns Hopkins University | Albumin-bound protein/peptide complex as a biomarker for disease |
| ES3039965T3 (en) | 2011-03-01 | 2025-10-28 | NuCana plc | Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer |
| EP3048904A2 (en) * | 2013-09-25 | 2016-08-03 | Pronutria Biosciences, Inc. | Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof |
| MD20170035A2 (ro) * | 2014-10-31 | 2017-09-30 | Ngm Biopharmaceuticals Inc | Compoziţii şi metode de utilizare pentru tratamentul tulburărilor metabolice |
| WO2017109706A1 (en) * | 2015-12-22 | 2017-06-29 | Novartis Ag | Methods of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15) |
| CN110087666B (zh) | 2016-11-13 | 2024-04-30 | 想象制药公司 | 用于治疗糖尿病、高血压和高胆固醇血症的组合物和方法 |
| JP2021510157A (ja) * | 2018-01-09 | 2021-04-15 | イマジン ファーマ、エルエルシー | 内皮細胞機能障害を調節するためのｒｐｓ２ペプチドの使用 |
-
2017
- 2017-11-13 CN CN201780069543.0A patent/CN110087666B/zh active Active
- 2017-11-13 US US15/811,060 patent/US10548941B2/en active Active
- 2017-11-13 KR KR1020197015784A patent/KR102497242B1/ko active Active
- 2017-11-13 JP JP2019524445A patent/JP2020502056A/ja active Pending
- 2017-11-13 BR BR112019009511-0A patent/BR112019009511A2/pt active Search and Examination
- 2017-11-13 WO PCT/US2017/061343 patent/WO2018089909A1/en not_active Ceased
- 2017-11-13 EP EP17868911.3A patent/EP3538124A4/en active Pending
- 2017-11-13 AU AU2017357052A patent/AU2017357052B2/en active Active
- 2017-11-13 MX MX2019005466A patent/MX2019005466A/es unknown
-
2019
- 2019-06-28 US US16/455,878 patent/US10751384B2/en active Active
-
2022
- 2022-05-31 AU AU2022203741A patent/AU2022203741B2/en active Active
-
2023
- 2023-02-07 JP JP2023016485A patent/JP7711967B2/ja active Active
-
2025
- 2025-07-03 JP JP2025113059A patent/JP2025163025A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025163025A5 (enExample) | ||
| Hjortrup et al. | Influence of diabetes mellitus on operative risk | |
| RU2546520C2 (ru) | Применение ave0010 для производства лекарственного средства для лечения сахарного диабета 2 типа | |
| US9289493B2 (en) | Method for treating inflammatory conditions with mucosally administered interleukin-2 | |
| RU2684398C2 (ru) | Состав с постоянным соотношением инсулина гларгина/ликсизенатида | |
| CN1711101A (zh) | 孤独症及相似障碍的治疗 | |
| JP2020502056A5 (enExample) | ||
| TW200946108A (en) | Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium level in the blood | |
| McElwain et al. | Remission induction with cytosine arabinoside and L-asparaginase in acute lymphoblastic leukaemia | |
| JP2804979B2 (ja) | エイズ治療および阻害剤 | |
| JPH11246433A (ja) | 心筋梗塞治療剤 | |
| JP2003519088A (ja) | Ｈｉｖ感染患者の治療および予防のためのｇｓｓｇレダクターゼの使用 | |
| CN115554297B (zh) | 一种金雀花碱的新医药用途及其药物制剂 | |
| US6355682B1 (en) | Treatment of acute renal failure by administration of N-acetylcysteine | |
| JP2004508419A (ja) | 心電図のｑｔ間隔の短縮 | |
| JP3718849B2 (ja) | 抗マラリア剤 | |
| RU2061484C1 (ru) | Способ лечения острого периода инфаркта миокарда | |
| AU2001286092A1 (en) | Reduction of the electrocardiographic OT interval | |
| Mao et al. | Rapid antihypertensive effect of rhomotoxin in 105 hypertension cases | |
| JP2875541B2 (ja) | 血行再建術後の再閉塞防止剤 | |
| US5972903A (en) | Method for promoting angiogenesis using heparin and adenosine | |
| JPH0618779B2 (ja) | 造血機能回復促進剤 | |
| RU2189207C2 (ru) | Способ лечения кератитов | |
| JP3627801B2 (ja) | 副鼻腔炎の予防および／または治療剤 | |
| SU1438791A1 (ru) | Способ лечени острых неспецифических воспалительных заболеваний м гких тканей лица и шеи |